epirubicin has been researched along with Cancer of Nose in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Y; Fu, X; Li, L; Li, X; Li, Z; Nan, F; Sun, Z; Wang, X; Zhang, M; Zhang, X; Zhao, L | 1 |
| Gu, YJ; Guo, X; Guo, Y; Lu, H; Ma, X; Pang, Z; Wang, B | 1 |
| Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG | 1 |
| Chan, JK; Cheung, MM; So, JC; Wong, KF | 1 |
1 trial(s) available for epirubicin and Cancer of Nose
| Article | Year |
|---|---|
A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Invasiveness; Nose Neoplasms; Pharyngeal Neoplasms; Prednisone; Prognosis; Radiation Injuries; Semustine; Survival Rate; Vincristine; Young Adult | 2009 |
3 other study(ies) available for epirubicin and Cancer of Nose
| Article | Year |
|---|---|
ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target.
Topics: Apoptosis; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Epirubicin; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Lentivirus; Lymphoma, Extranodal NK-T-Cell; Molecular Targeted Therapy; Multidrug Resistance-Associated Proteins; Nasal Mucosa; Neoplasm Proteins; Nose Neoplasms; Real-Time Polymerase Chain Reaction; Recombinant Fusion Proteins; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Transduction, Genetic | 2015 |
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis | 2003 |
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization; Killer Cells, Natural; Lymphoma; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisone; Radiotherapy; RNA, Viral; Treatment Outcome; Vincristine | 2001 |